News | Cardiac Diagnostics | March 23, 2016

Tackling Cardiovascular Health Risks in College Football Players

Research gives clinicians comparative benchmarks for collegiate athletes' hearts

college football players, cardiovascular health risks, Texas A&M University, Stephen Crouse

Image courtesy of Texas A&M University

March 23, 2016 — Recent research published in The American Journal of Cardiology and led by Stephen Crouse, Ph.D., is shedding light on the healthy cardiac parameters and blood pressure levels of collegiate American-style football (ASF) athletes.

Crouse, professor of kinesiology and joint professor of internal medicine at Texas A&M University, and his colleagues in the Department of Health and Kinesiology and the Health Science Center College of Medicine, studied 80 incoming Texas A&M football players. Data was collected over three years as part of a pre-participation physical exam. The purpose was to describe heart characteristics and blood pressure values in collegiate ASF athletes compared with normal values.

“Before this study, there weren’t baseline comparative benchmarks for screening and follow up of incoming NCAA [National Collegiate Athletic Association] football players for cardiac anatomical variations, blood pressure, and training effect,” said John Erwin, III, M.D., associate professor of internal medicine and co-author of this research. “These results should serve as a basis to better define normal and abnormal findings in athletes’ hearts.”

“The aspect of health in athletes is a really important component of what we do here at Texas A&M,” Crouse added. “Even though performance is very important, health of the athletes is critical.”

The heart trains just like any other muscle — it grows larger the more the athlete exercises. However, in the non-athlete population, a larger heart and thicker muscle can be associated with the risk of cardiovascular disease.

Football athletes are known to have larger hearts because, in part, they are larger people. This study confirmed that, finding enlarged hearts and increased ventricular wall thickness. The key is to adjust the heart size by the size of the individual to see if such adjustment brings the heart back into a normal range. If not, that could indicate there is an enlargement that may not be healthy.

“Our study doesn’t really tell us much about how well these athletes are going to perform on the field,” Crouse said. “We don’t say anything about having a bigger heart making you a better athlete. All we’re trying to do is get information that will help us make health judgments and help the athletes be healthier.”

Another aspect of cardiac health is blood pressure, and the researchers measured the occurrence of high blood pressure in football players. Researchers found that 64 percent of the study participants had pre-hypertension, meaning their blood pressure was elevated above what is normal but not enough to be considered high blood pressure. The study shows it is possible the elevated blood pressure represents an adaptation to the high-intensity training and could be reversed at the end of training.

Still, the researchers see these results as confirming the importance of monitoring athletes’ blood pressure on a regular basis throughout their college athletic career and beyond.

“What we would like to be able to do as time goes on is to follow these athletes from year to year as they train in our program to really be able to document what happens to their heart structure and function as we go through their training throughout their collegiate career,” Crouse said. “Hopefully we will be able to follow them after that and maybe we can track and see if there are certain kinds of cardiac issues that can predict them not being healthy in the future.”

For more information: www.ajconline.org

Related Content

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

News | Cardiac Diagnostics | July 29, 2021
July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation Ambula
The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

News | Cardiac Diagnostics | July 01, 2021
July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc.
Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Detecting heart disease with OCT imaging of the eye.Getty Images

Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Getty Images
 

News | Cardiac Diagnostics | March 08, 2021
March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potent
Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia.

Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG strip on a smartphone. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia. 

News | Cardiac Diagnostics | March 03, 2021
March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management s
A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images Health disparities in cardiovascular disease.

A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images

News | Cardiac Diagnostics | February 02, 2021
February 2, 2021 — A new study has found in the U.S.
A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

News | Cardiac Diagnostics | January 06, 2021
January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects
The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia. 

News | Cardiac Diagnostics | October 06, 2020
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc.
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en